TY - GEN
T1 - Biomimetic apoptotic erythrocyte membrane-coated microparticles for enhanced tolerance induction
AU - Rhodes, Kelly R.
AU - Meyer, Randall A.
AU - State, Claire M.
AU - Green, Jordan J.
N1 - Publisher Copyright:
© 2019 Omnipress - All rights reserved.
PY - 2019
Y1 - 2019
N2 - Statement of Purpose: To combat autoimmunity and promote immune tolerance, there is growing interest in therapies that exploit antigen presenting cell (APC)-mediated apoptotic clearance pathways. Tolerized APCs inhibit pathogenic effector T cells and promote formation of protective regulatory T cells.1 Delivery of self-antigen coupled to apoptotic cells has been shown to induce antigen-specific tolerance to treat autoimmune diseases such as multiple sclerosis without the need for broad immunosuppressants.2 However, cell-based therapies are expensive and complex to implement, and alternative “off-the-shelf" strategies are needed. Biocompatible micro-and nanocarriers coated with naturally-derived cell membranes possess key advantages of particle-based delivery platforms while retaining essential cell membrane features to activate apoptotic clearance pathways and promote tolerance. Here we investigate the ability of polymeric microparticles (MPs) with a novel apoptotic red blood cell (RBC)-derived surface coating to enhance APC-mediated tolerance induction. We demonstrate that this apoptotic coating speeds up clearance from systemic circulation, increases APC-mediated uptake, and promotes APC tolerization.
AB - Statement of Purpose: To combat autoimmunity and promote immune tolerance, there is growing interest in therapies that exploit antigen presenting cell (APC)-mediated apoptotic clearance pathways. Tolerized APCs inhibit pathogenic effector T cells and promote formation of protective regulatory T cells.1 Delivery of self-antigen coupled to apoptotic cells has been shown to induce antigen-specific tolerance to treat autoimmune diseases such as multiple sclerosis without the need for broad immunosuppressants.2 However, cell-based therapies are expensive and complex to implement, and alternative “off-the-shelf" strategies are needed. Biocompatible micro-and nanocarriers coated with naturally-derived cell membranes possess key advantages of particle-based delivery platforms while retaining essential cell membrane features to activate apoptotic clearance pathways and promote tolerance. Here we investigate the ability of polymeric microparticles (MPs) with a novel apoptotic red blood cell (RBC)-derived surface coating to enhance APC-mediated tolerance induction. We demonstrate that this apoptotic coating speeds up clearance from systemic circulation, increases APC-mediated uptake, and promotes APC tolerization.
UR - http://www.scopus.com/inward/record.url?scp=85065418261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065418261&partnerID=8YFLogxK
M3 - Conference contribution
AN - SCOPUS:85065418261
T3 - Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium
SP - 236
BT - Society for Biomaterials Annual Meeting and Exposition 2019
PB - Society for Biomaterials
T2 - 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence
Y2 - 3 April 2019 through 6 April 2019
ER -